Andrea Weiss Selected Research

dichloro(4- cymene)(1,3,5- triaza- 7- phosphatricyclo(3.3.1.1)decane)ruthenium(II)

1/2017	Combination of ruthenium(II)-arene complex [Ru(η6-p-cymene)Cl2(pta)] (RAPTA-C) and the epidermal growth factor receptor inhibitor erlotinib results in efficient angiostatic and antitumor activity.
3/2015	Angiostatic treatment prior to chemo- or photodynamic therapy improves anti-tumor efficacy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrea Weiss Research Topics

Disease

17	Neoplasms (Cancer) 12/2021 - 07/2012
3	Renal Cell Carcinoma (Grawitz Tumor) 10/2020 - 01/2020
3	Chronic Disease (Chronic Diseases) 01/2020 - 01/2020
3	Carcinoma (Carcinomatosis) 01/2018 - 03/2015
2	COVID-19 01/2023 - 01/2022
2	Disease Progression 01/2020 - 01/2020
1	Neoplasm Metastasis (Metastasis) 10/2020
1	Pulmonary Arterial Hypertension 01/2020
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2020
1	Idiopathic Pulmonary Fibrosis 01/2020
1	Heart Failure 01/2020
1	Melanoma (Melanoma, Malignant) 10/2019
1	Ovarian Neoplasms (Ovarian Cancer) 01/2018
1	Communicable Diseases (Infectious Diseases) 02/2016
1	Inflammation (Inflammations) 03/2014
1	Hypoxia (Hypoxemia) 03/2014
1	Eye Diseases (Eye Disease) 08/2012
1	Macular Degeneration (Age-Related Maculopathy) 07/2012
1	Obesity 07/2011
1	Type 2 Diabetes Mellitus (MODY) 07/2011
1	Overweight 07/2011

Drug/Important Bio-Agent (IBA)

7	Drug CombinationsIBA 11/2020 - 07/2015
3	Sunitinib (Sutent)FDA Link 10/2020 - 10/2019
3	1-phenyl-3,3-dimethyltriazene (PDT)IBA 03/2014 - 07/2012
2	Histone Deacetylases (Histone Deacetylase)IBA 10/2020 - 05/2017
2	Phosphotransferases (Kinase)IBA 09/2020 - 03/2015
2	dichloro(4- cymene)(1,3,5- triaza- 7- phosphatricyclo(3.3.1.1)decane)ruthenium(II)IBA 01/2017 - 03/2015
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2017 - 03/2015
2	Tyrosine Kinase InhibitorsIBA 03/2015 - 03/2014
1	iodoHis(3)- neurokinin A (INKA)IBA 09/2020
1	Cisplatin (Platino)FDA LinkGeneric 01/2018
1	LigandsIBA 01/2018
1	MethyltransferasesIBA 05/2017
1	Antineoplastic Agents (Antineoplastics)IBA 05/2017
1	DNA (Deoxyribonucleic Acid)IBA 05/2017
1	4-cymene (p-cymene)IBA 01/2017
1	MetalsIBA 01/2017
1	Organometallic CompoundsIBA 01/2017
1	RutheniumIBA 01/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2015
1	Axitinib (AG 013736)IBA 03/2015
1	SolutionsIBA 11/2014

Therapy/Procedure

13	Therapeutics 01/2020 - 07/2012
6	Palliative Care (Palliative Therapy) 01/2023 - 01/2020
3	Drug Therapy (Chemotherapy) 11/2020 - 05/2017
3	Photochemotherapy (Photodynamic Therapy) 03/2015 - 08/2012
1	Terminal Care (Care, Terminal) 12/2021
1	Lung Transplantation 01/2020
1	Organ Transplantation 02/2016
1	Biliopancreatic Diversion 07/2011